Senomyx to Webcast Corporate Presentation at the 2009 BIOCOM Investor Conference
2009-10-20
-
Senomyx, Inc.
Senomyx, Inc., a leading company focused on using proprietary taste receptor technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that John Poyhonen, the Company's President and Chief Operating Officer, will present a corporate overview on Tuesday, October 27, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) during the 2009 BIOCOM Investor Conference. The conference is taking place at The Hyatt Regency La Jolla in San Diego, California. During his presentation, Mr. Poyhonen will discuss corporate developments including the Company's pipeline of novel flavor ingredients and its business strategy.
To access the live presentation or a subsequent archived recording, please log onto Senomyx's website at http://investor.senomyx.com. The archived webcast will be available for 30 days following the presentation. Please connect to Senomyx's website prior to the start of the webcast to ensure adequate time to download any software that may be necessary.
About Senomyx, Inc. (www.senomyx.com)
Senomyx is a leading company using proprietary taste receptor technologies to discover and develop novel flavor ingredients in the savory, sweet, salt, bitter, and cooling areas. Senomyx has entered into product discovery, development, and commercialization collaborations with seven of the world's foremost food, beverage, and ingredient supply companies: Ajinomoto Co., Inc., Cadbury plc, Campbell Soup Company, The Coca-Cola Company, Firmenich SA, Nestle SA, and Solae. Nestle is currently marketing products that contain one of Senomyx's flavor ingredients. For more information, please visit www.senomyx.com.
|
|
|
Related Articles :
Senomyx Reports FY08 Q4 and Year-End Results (2009-02-12)
Senomyx, Inc., has announced their FY08 Q4 results, reporting revenues for the fourth quarter were $3.5 million, compared to $6.4 million for the same period in 2007, a decrease of 45%. Revenues were $17.2 million for the full 2008 year, compared to $18.2 million for 2007, a decrease of 6%. The decrease in revenue for the fourth quarter and full year is primarily due to higher non-recurring upfront payment revenue in 2007 compared to 2008.
Senomyx Announces FY09 Q1 Results (2009-05-07)
Senomyx, Inc., has announced their FY09 Q1 results, reporting revenues were $3.5 million, compared to $6.1 million for the same period in 2008. The decrease in revenue for the first quarter was due to $3.0 million in non-recurring upfront payment revenue in 2008 compared to none in 2009, partially offset by higher R&D and milestone funding and commercial revenue in 2009 compared to 2008. Most significantly, under its collaboration with Ajinomoto, in 2007 the Company received an $8.0 million upfront payment of which $2.7 million was recognized as revenue in the first quarter of 2008 and none of which was recognized as revenue in the first quarter of 2009.
Senomyx Announces Management Team Promotions (2009-09-25)
Senomyx, Inc., has announced that John Poyhonen has been promoted to President and will also assume the newly created position of Chief Operating Officer. In addition, Tony Rogers has been promoted to Vice President and Chief Financial Officer. Kent Snyder will continue in the positions of Chairman of the Board of Directors and Chief Executive Officer.
|
|
|
|